Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Novartis
Chubb
Queensland Health
Chinese Patent Office
Accenture
Deloitte
US Department of Justice
Baxter

Generated: January 18, 2018

DrugPatentWatch Database Preview

DOXYCYCLINE HYCLATE Drug Profile

« Back to Dashboard

When do Doxycycline Hyclate patents expire, and when can generic versions of Doxycycline Hyclate launch?

Doxycycline Hyclate is a drug marketed by Pliva, Medicis, Actavis Labs Fl Inc, Amneal Pharms, Chartwell Life Sci, Halsey, Heather, Hikma Intl Pharms, Interpharm, Mutual Pharm, Mylan, Par Pharm, Pvt Form, Ranbaxy, Sun Pharm Industries, Superpharm, Warner Chilcott, Watson Labs, West-ward Pharms Int, Actavis Elizabeth, Heritage Pharms Inc, Impax Labs Inc, Mylan Pharms Inc, Prinston Inc, Amneal Pharms Co, Caribe Holdings, Epic Pharma Llc, Ivax Sub Teva Pharms, Lannett, Larken Labs, Lupin Ltd, Mayne Pharma Inc, Novel Labs Inc, Vintage Pharms, and Zydus Pharms Usa Inc. and is included in fifty-two NDAs.

The generic ingredient in DOXYCYCLINE HYCLATE is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Drug patent expirations by year for DOXYCYCLINE HYCLATE
Pharmacology for DOXYCYCLINE HYCLATE
Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

US Patents and Regulatory Information for DOXYCYCLINE HYCLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mutual Pharm DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062391-001 Sep 30, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 090134-002 Dec 14, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062594-001 Dec 5, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 090431-004 Apr 29, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Life Sci DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062505-001 Sep 11, 1984 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 090505-001 Dec 28, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 090431-002 Dec 28, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062421-001 Feb 2, 1983 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Epic Pharma Llc DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 065182-001 May 13, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062479-002 Dec 23, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
UBS
McKesson
Johnson and Johnson
Fuji
Farmers Insurance
Federal Trade Commission
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot